Taiwan's TWi hires Teva executive after ending U.S. marketing pact; Astellas gets FDA Cresemba nod;

> ANI Pharmaceuticals beefed up its generics portfolio with Teva ($TEVA) deal. Release

> Taiwan's TWi hired a Teva executive after breaking with Israeli firm on U.S. marketing plans. Release

> TWi Biotechnology got a Taiwan FDA nod for rare drug designation on its candidate for treating epidermolysis bullosa simplex. Release

> Japan's Astellas won a FDA nod on Cresemba. Release

> Japan's Shimadzu is looking past China for Asian growth with Southeast Asia in sight. Story